Literature DB >> 23111945

Second response to the letter to the editor referencing the manuscript the "use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial".

L Kottschade, J Sloan, C Loprinzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23111945     DOI： 10.1007/s00520-012-1642-1

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  2 in total

1.  Vitamin E for preventing chemotherapy-induced peripheral neuropathy.

Authors:  Andreas A Argyriou; Haralabos P Kalofonos
Journal:  Support Care Cancer       Date:  2011-01-14       Impact factor: 3.603

2.  The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.

Authors:  Lisa A Kottschade; Jeff A Sloan; Miroslaw A Mazurczak; David B Johnson; Bronagh P Murphy; Kendrith M Rowland; Deanne A Smith; Alan R Berg; Philip J Stella; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2010-10-09       Impact factor: 3.603
  2 in total
  2 in total

1.  The search for treatments to reduce chemotherapy-induced peripheral neuropathy.

Authors:  Deirdre R Pachman; Charles L Loprinzi; Axel Grothey; Lauren E Ta
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

2.  Self-management of oxaliplatin-related peripheral neuropathy in colorectal cancer survivors.

Authors:  Cindy Tofthagen; Laura Gonzalez; Constance Visovsky; Alex Akers
Journal:  Chemother Res Pract       Date:  2013-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.